TILL TRANSAKTIONER
Hälsovård

Youtopia Vitacura has completed a finance structuring

November 2021 — Youtopia Vitacura SpA. has raised funds to finance a new project.

Youtopia was born in 2015 with the opening of Youtopia Trapenses, a club that came to revolutionize the wellness industry in Chile. The added value that the company offers lies in its integral service with personalized plans, with access to fitness programs, swimming pool, studios, spa, therapy and deli, among others. The Youtopia group is comprised of three business units: Youtopia Holding, which develops and operates its own clubs and, in future, those of third parties; Youtopia Trapenses, a club that opened in 2015 and in 2019 had 1,850 members; and Youtopia Vitacura, a new project to be financed. The project was awarded a 40-year concession in 2019. It includes three stages: remodeling the club to be able to have 3,100 members, a new wellness clinic and the construction of 600 subway parking spaces. This will take place in the former Balthus Vitacura, located in the BordeRío sector.

Our role in the transaction

Oaklins’ team in Chile acted as financial advisor to Youtopia to carry out the structuring of the financing of the three stages of the Youtopia Vitacura project.

Prata med transaktionsteamet

Sebastián Cereceda

Partner
Santiago, Chile
Oaklins LarrainVial

Antonio Benvenuto

Associate Director
Santiago, Chile
Oaklins LarrainVial

Relaterade transaktioner

Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Hälsovård

Katalyst Diagnostics has been acquired by Cruinn Diagnostics

Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.

Lär dig mer
Life & Mobility has attracted investor Bolster Investment Partners
Riskkapital | Hälsovård

Life & Mobility has attracted investor Bolster Investment Partners

Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.  

Lär dig mer
Synergia and Bolster have secured acquisition financing for Life & Mobility
Riskkapital | Hälsovård

Synergia and Bolster have secured acquisition financing for Life & Mobility

Synergia Capital Partners and Bolster Investment Partners have partnered with Life & Mobility, a leading Dutch developer and manufacturer of premium mobility and rehabilitation solutions. The partnership marks an important next step in Life & Mobility’s growth trajectory, focused on further international expansion, continued product innovation and strengthening its leading market position.

Lär dig mer